[
    [
        {
            "time": "",
            "original_text": "医药行业周报：本周医药指数上涨3.75% 建议关注春节疫情防控影响",
            "features": {
                "keywords": [
                    "医药行业",
                    "医药指数",
                    "上涨",
                    "春节",
                    "疫情防控"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：本周医药指数上涨3.75% 建议关注春节疫情防控影响",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业2020业绩前瞻：2020板块分化明显 下半年医疗服务等有序复苏",
            "features": {
                "keywords": [
                    "医药生物",
                    "2020业绩",
                    "板块分化",
                    "医疗服务",
                    "复苏"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2020业绩前瞻：2020板块分化明显 下半年医疗服务等有序复苏",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：新冠变异后是否需要常态化免疫加强？智飞新高后继续强烈看好",
            "features": {
                "keywords": [
                    "医药生物",
                    "新冠变异",
                    "常态化免疫",
                    "智飞",
                    "新高",
                    "强烈看好"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：新冠变异后是否需要常态化免疫加强？智飞新高后继续强烈看好",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]